Patent details
EP3204040 Title: TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS
Basic Information
- Publication number:
- EP3204040
- PCT Application Number:
- US2015054899
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP158486910
- PCT Publication Number:
- WO2016057898
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS
- French Title of Invention:
- TRAITEMENT DU CANCER PAR AGONISTE(S) DU TLR9 AVEC DES INHIBITEURS DU POINT DE CONTRÔLE
- German Title of Invention:
- BEHANDLUNG VON KREBS MIT TLR9-AGONIST UND CHECKPOINT-HEMMERN
- SPC Number:
Dates
- Filing date:
- 09/10/2015
- Grant date:
- 08/12/2021
- EP Publication Date:
- 16/08/2017
- PCT Publication Date:
- 14/04/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/12/2021
- EP B1 Publication Date:
- 08/12/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/10/2022
- Expiration date:
- 09/10/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/03/2022
- Name:
- Idera Pharmaceuticals, Inc.
- Address:
- 505 Eagleview Boulevard, Suite 212, Exton, PA 19341, United States (US)
History of Owners
- From:
- 01/12/2021
- To:
- 18/03/2022
- Name:
- Idera Pharmaceuticals, Inc.
- Address:
- 167 Sidney Street, Cambridge, MA 02319, United States (US)
Inventor
1
- Name:
- JIANG, Wayne
- Address:
- United States (US)
2
- Name:
- WANG, Daqing
- Address:
- United States (US)
3
- Name:
- AGRAWAL, Sudhir
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201462062274 P
- Priority Date:
- 10/10/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562218934 P
- Priority Date:
- 15/09/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/7115; A61K 39/00; A61K 39/39; A61K 45/06; A61K 9/00; C07K 14/435; A61N 5/00; A61P 35/00; A61P 35/02; A61P 35/04; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202149
- Publication date:
- 08/12/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202203
- Publication date:
- 19/01/2022
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202216
- Publication date:
- 20/04/2022
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|